Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntelliAM AI Regulatory News (INT.PL)

Share Price Information for IntelliAM AI (INT.PL)

Share Price is delayed by 15 minutes
Get Live Data
80.00    0.00 (0.00%)
Bid:
70.00
Ask:
90.00
Spread: 20.00 (28.571%)
Market Cap: £15.68m
INT.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday IntelliAM AI Share Chart

Contract

1 Oct 2025 07:00

RNS Number : 4981B
IntelliAM AI PLC
01 October 2025
 

1 October 2025

 

IntelliAM AI plc

("IntelliAM" or the "Company")

 

IntelliAM Wins Multi-Site AI Expansion with Hovis - Ninefold Increase on Initial Contract

IntelliAM AI plc (AQSE: INT), the software company transforming productivity in the manufacturing industry through artificial intelligence and machine learning, is delighted to announce a major expansion of its commercial partnership with Hovis Limited.

As announced on 16 September 2024, IntelliAM secured an initial contract with Hovis to deliver reliability consultancy services across three key sites, underpinned by the IntelliAM AI platform. The project successfully delivered gap analyses, criticality assessments, and tailored maintenance strategies that enabled targeted, data-driven improvements to production reliability.

Following these proven results, Hovis has now awarded IntelliAM a substantially expanded contract which represents a ninefold increase on the original agreement.

The expanded engagement will see:

· Full deployment of the IntelliAM AI platform across multiple manufacturing sites

· Integration of IntelliAM smart sensor interfaces across production lines

· Ongoing consultancy services to drive measurable gains in reliability, productivity, and asset availability.

The anticipated productivity improvements are expected to deliver full return on investment within the first year, accelerating Hovis' journey towards AI-powered, proactive manufacturing excellence.

Chris Bradley, Chief Operations Officer of Hovis Limited, said:

"We are pleased to be making this next step investment in IntelliAM's services and AI platform, following a detailed analysis of the outcomes from our initial engagement."

Tom Clayton, Chief Executive Officer of IntelliAM AI plc, commented:

"This expanded contract represents a significant milestone for IntelliAM, validating the commercial value of our AI-driven solutions. We are proud to be deepening our relationship with Hovis and to be helping them lead the way in transforming UK manufacturing productivity."

Chris Lawton, Head of Engineering at Hovis, said:

"This is a game-changing shift for our business. It not only boosts reliability and cuts downtime but also empowers our engineers, reduces pressure on the shop floor, and ensures our customers can continue to rely on us every day."

 

 

About Hovis

Hovis® Limited is a baking business owned by Endless LLP. Hovis is based in High Wycombe and employs 2,800 people in eight bakeries, one flourmill and three distribution centres across the UK. Hovis is proud to be part of a baking heritage that goes back more than 130 years, now delivering more than a million of its much-loved loaves every day throughout the UK and Ireland. Not just Hovis® loaves, Hovis also bakes Mother's Pride®, Ormo® and other bakery products too. Hovis prides itself on the taste and quality of all its bakery products, but then they all do have Hovis® tradition baked into them.

About IntelliAM AI plc

IntelliAM AI plc is a software company leveraging artificial intelligence and machine learning to deliver measurable productivity improvements in manufacturing and engineering. The IntelliAM platform collects and analyses vast machine and operational data to provide actionable insights that enhance reliability, supply-chain efficiency, energy use, and sustainability.

Enquiries:

 

IntelliAM AI plc +44 114 299 5007

Tom Clayton, Chief Executive Officer

Daud Khan, Chief Financial Officer

Oberon Capital - AQSE Corporate Adviser and Broker +44 203 179 5300

Adam Pollock

Nick Lovering

Mike Seabrook

Square1 Consulting - Financial PR +44 207 929 5599

David Bick +44 7831 381201

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXDBLFXEKLBBBF
12
Date   Source Headline
8th Jul 20267:00 amRNSNew Customer Wins
7th Jul 20267:07 amRNSFundraising to augment growth in US operations
6th Jul 20267:30 amRNSLaunch of Investor Hub
20th May 20267:00 amRNSUS Expansion and CRO Appointment
16th Apr 20267:00 amRNSTrading Update
1st Apr 20267:00 amRNSAcquisition of RBM Lubrications
19th Mar 20267:00 amRNSAppointment of Corporate Adviser and Broker
6th Jan 20267:00 amRNSOrders from New Customer in Frozen Food Vertical
29th Dec 20257:00 amRNSHolding(s) in Company
29th Dec 20257:00 amRNSHolding(s) in Company
10th Dec 20258:17 amRNSHolding(s) in Company
2nd Dec 20258:38 amRNSResult of Oversubscribed WRAP Retail Offer
25th Nov 20257:05 amRNSContract
25th Nov 20257:00 amRNSHalf-year Financial Report
24th Nov 202512:35 pmRNSWRAP Retail Offer
24th Nov 202512:30 pmRNSPlacing and Retail Offer
4th Nov 20257:00 amRNSFirst Half Trading Statement
27th Oct 20257:35 amRNSMove from Access to Apex segment
3rd Oct 20253:45 pmRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSContract
24th Sep 20257:00 amRNSContract
12th Sep 20257:00 amRNS-RManufacturing Tech Award 2025
9th Sep 202512:33 pmRNSResult of Annual General Meeting
4th Sep 20257:00 amRNSDirectorate Change
12th Aug 20257:00 amRNSAnnual Financial Report
8th Aug 20253:00 pmRNSHolding(s) in Company
25th Jul 20257:00 amRNS-RAppointment of Vice President of Sales
7th Jul 20257:00 amRNSFinal Results
3rd Jul 20257:00 amRNSStrategic Partnership Agreement with CTC in USA
2nd Jul 20257:00 amRNSContract
1st Jul 20257:00 amRNSDirectorate Change
27th May 20257:00 amRNSDirector/PDMR Shareholding
12th May 20257:00 amRNSTrading Update
2nd May 20257:00 amRNSDirectorate Change
26th Mar 20257:00 amRNS-RSenior Management Team Strengthened
20th Mar 20252:25 pmRNSDirector/PDMR Shareholding
24th Feb 20251:00 pmRNSDeath of a Non-Executive Director
13th Jan 20257:00 amRNSDirectorate Change
18th Dec 20243:57 pmRNSDirector/PDMR Shareholding
17th Dec 20247:00 amRNSDirector/PDMR Shareholding
16th Dec 20247:00 amRNSDirector/PDMR Shareholding
12th Dec 20244:51 pmRNSDirector/PDMR Shareholding
11th Dec 20247:00 amRNSLetter of Intent Signed
9th Dec 20247:00 amRNSHalf-year Report
6th Nov 20241:13 pmRNSResult of Annual General Meeting
10th Oct 20243:30 pmRNSPosting of Annual Report and Notice of AGM
25th Sep 20247:00 amRNSAnnual Financial Report
16th Sep 20247:00 amRNSContract
7th Aug 20247:00 amRNSContract
11th Jul 20247:00 amRNSContract
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.